467 6. Complicanze tardive splant Recipients: Guidelines of the 2017 European Conference on Infections in Leukaemia (ECIL 7). Lancet Infect Dis 2019, 19, e200–e212, doi:10.1016/S1473-3099(18)30600-5. 14. Bacigalupo, A.; Metafuni, E.; Amato, V.; Marquez Algaba, E.; Pagano, L. Reducing Infectious Complications after Allogeneic Stem Cell Transplant. Expert Rev Hematol 2020, 13, 1235–1251, do i:10.1080/17474086.2020.1831382. 15. Girmenia, C.; Raiola, A.M.; Piciocchi, A.; Algarotti, A.; Stanzani, M.; Cudillo, L.; Pecoraro, C.; Guidi, S.; Iori, A.P.; Montante, B.; et al. Incidence and Outcome of Invasive Fungal Diseases after Allogeneic Stem Cell Transplantation: A Prospective Study of the Gruppo Italiano Trapianto Midollo Osseo (GITMO). Biol Blood Marrow Transplant 2014, 20, 872–880, doi:10.1016/j.bbmt.2014.03.004. 16. Foord, A.M.; Cushing-Haugen, K.L.; Boeckh, M.J.; Carpenter, P.A.; Flowers, M.E.D.; Lee, S.J.; Leisenring, W.M.; Mueller, B.A.; Hill, J.A.; Chow, E.J. Late Infectious Complications in Hematopoietic Cell Transplantation Survivors: A Population-Based Study. Blood Adv 2020, 4, 1232–1241, doi:10.1182/bloodadvances.2020001470. 17. Girmenia, C.; Barosi, G.; Piciocchi, A.; Arcese, W.; Aversa, F.; Bacigalupo, A.; Bandini, G.; Bosi, A.; Busca, A.; Castagnola, E.; et al. Primary Prophylaxis of Invasive Fungal Diseases in Allogeneic Stem Cell Transplantation: Revised Recommendations from a Consensus Process by Gruppo Italiano Trapianto Midollo Osseo (GITMO). Biol Blood Marrow Transplant 2014, 20, 1080–1088, doi:10.1016/j.bbmt.2014.02.018. 18. Maertens, J.; Cesaro, S.; Maschmeyer, G.; Einsele, H.; Donnelly, J.P.; Alanio, A.; Hauser, P.M.; Lagrou, K.; Melchers, W.J.G.; Helweg-Larsen, J.; et al. ECIL Guidelines for Preventing Pneumocystis Jirovecii Pneumonia in Patients with Haematological Malignancies and Stem Cell Transplant Recipients. J Antimicrob Chemother 2016, 71, 2397–2404, doi:10.1093/jac/dkw157. 19. Robin, C.; Thiebaut, A.; Alain, S.; Sicre de Fontbrune, F.; Berceanu, A.; D’Aveni, M.; Ceballos, P.; Redjoul, R.; Nguyen-Quoc, S.; Bénard, N.; et al. Letermovir for Secondary Prophylaxis of Cytomegalovirus Infection and Disease after Allogeneic Hematopoietic Cell Transplantation: Results from the French Compassionate Program. Biol Blood Marrow Transplant 2020, 26, 978–984, doi:10.1016/j.bbmt.2020.01.027. 20. Styczyński, J.; Tridello, G.; Xhaard, A.; Medinger, M.; Mielke, S.; Taskinen, M.; Blijlevens, N.; Rodriguez, M.A.B.; Solano, C.; Nikolousis, E.; et al. Use of Letermovir in Off-Label Indications: Infectious Diseases Working Party of European Society of Blood and Marrow Transplantation Retrospective Study. Bone Marrow Transplant 2021, 56, 1171–1179, doi:10.1038/s41409-020-01166-w. 21. Styczynski, J.; Reusser, P.; Einsele, H.; de la Camara, R.; Cordonnier, C.; Ward, K.N.; Ljungman, P.; Engelhard, D.; Second European Conference on Infections in Leukemia Management of HSV, VZV and EBV Infections in Patients with Hematological Malignancies and after SCT: Guidelines from the Second European Conference on Infections in Leukemia. Bone Marrow Transplant 2009, 43, 757–770, doi:10.1038/bmt.2008.386. 22. Henze, L.; Buhl, C.; Sandherr, M.; Cornely, O.A.; Heinz, W.J.; Khodamoradi, Y.; Kiderlen, T.R.; Koehler, P.; Seidler, A.; Sprute, R.; et al. Management of Herpesvirus Reactivations in Patients with Solid Tumours and Hematologic Malignancies: Update of the Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Medical Oncology (DGHO) on Herpes Simplex Virus Type 1, Herpes Simplex Virus Type 2, and Varicella Zoster Virus. Ann Hematol 2022, 101, 491– 511, doi:10.1007/s00277-021-04746-y. 23. Stadtmauer, E.A.; Sullivan, K.M.; El Idrissi, M.; Salaun, B.; Alonso Alonso, A.; Andreadis, C.; Anttila, V.-J.; Bloor, A.J.; Broady, R.; Cellini, C.; et al. Adjuvanted Recombinant Zoster Vaccine in Adult Autologous Stem Cell Transplant Recipients: Polyfunctional Immune Responses and Lessons for Clinical Practice. Hum Vaccin Immunother 2021, 17, 4144–4154, doi:10.1080/21645515.2021.1953 346. 24. Baumrin, E.; Izaguirre, N.E.; Bausk, B.; Feeley, M.M.; Bay, C.P.; Yang, Q.; Ho, V.T.; Baden, L.R.; Issa, N.C. Safety and Reactogenicity of the Recombinant Zoster Vaccine after Allogeneic Hematopoietic Cell Transplantation. Blood Adv 2021, 5, 1585–1593, doi:10.1182/bloodadvances.2020003749. 25. Withers, B.; Clancy, L.; Burgess, J.; Simms, R.; Brown, R.; Micklethwaite, K.; Blyth, E.; Gottlieb, D. Establishment and Operation of a Third-Party Virus-Specific T Cell Bank within an Allogeneic Stem Cell Transplant Program. Biol Blood Marrow Transplant 2018, 24, 2433–2442, doi:10.1016/j.bbmt.2018.08.024. 26. Leen, A.M.; Bollard, C.M.; Mendizabal, A.M.; Shpall, E.J.; Szabolcs, P.; Antin, J.H.; Kapoor, N.; Pai, S.-Y.; Rowley, S.D.; Kebriaei, P.; et al. Multicenter Study of Banked Third-Party Virus-Specific T Cells to Treat Severe Viral Infections after Hematopoietic Stem Cell Transplantation. Blood 2013, 121, 5113–5123, doi:10.1182/blood-2013-02-486324. 27. Hirsch, H.H.; Martino, R.; Ward, K.N.; Boeckh, M.; Einsele, H.; Ljungman, P. Fourth European Conference on Infections in Leukaemia (ECIL-4): Guidelines for Diagnosis and Treatment of Human Respiratory Syncytial Virus, Parainfluenza Virus, Metapneumovirus, Rhinovirus, and Coronavirus. Clin Infect Dis 2013, 56, 258–266, doi:10.1093/cid/cis844. 28. Ljungman, P.; de la Camara, R.; Mikulska, M.; Tridello, G.; Aguado, B.; Zahrani, M.A.; Apperley, J.; Berceanu, A.; Bofarull, R.M.; Calbacho, M.; et al. COVID-19 and Stem Cell Transplantation; Results from an EBMT and GETH Multicenter Prospective Survey. Leukemia 2021, 35, 2885–2894, doi:10.1038/s41375-021-01302-5. 29. Cesaro, S.; Ljungman, P.; Mikulska, M.; Hirsch, H.H.; von Lilienfeld-Toal, M.; Cordonnier, C.; Meylan, S.; Mehra, V.; Styczynski, J.; Marchesi, F.; et al. Recommendations for the Management of COVID-19 in Patients with Haematological Malignancies or Haematopoietic Cell Transplantation, from the 2021 European Conference on Infections in Leukaemia (ECIL 9). Leukemia 2022, doi:10.1038/s41375-022-01578-1.
RkJQdWJsaXNoZXIy ODUzNzk5